A Parent-child Yoga Intervention for Reducing Attention Deficits in Children With Congenital Heart Disease: A Feasibility Study
Congenital Heart Disease, Child Development, Neurodevelopmental Disorders
About this trial
This is an interventional supportive care trial for Congenital Heart Disease focused on measuring Neurodevelopment, Attention, Yoga, Motor Skills, Parenting Stress, Congenital Heart Disease
Eligibility Criteria
To be eligible for the study, children need to meet the following inclusion criteria: diagnosis of CHD requiring heart surgery; aged 4 to 6 years old; poor attentional skills measured with Variability score (0.5 standard deviation below norms) at the Kiddie Conners Continuous Performance Test, 2nd Edition (K-CPT2), a sensitive measure for attentional impairments. This inclusion criteria is important since yoga intervention has shown larger effects on attention in children with greater difficulties before the intervention; parent willing to participate to the 8-week parent-child yoga intervention and the pre/post/6-month follow-up assessments; for children with ADHD medication (approx. 5% of the 4-to-6-year-olds at our neurocardiac clinic), parent accept to temporary stop it to at least 48h prior to each assessment. Exclusion criteria will be the following: having a medical contraindication to the practice of yoga; confirmed diagnosis of severe developmental or intellectual delay that would prevent successful completion of the planned study testing; presence of severe physical handicap that would preclude the child from participating in the yoga intervention without special adaptation; families who do not speak French or English (less than 3% of families followed in our clinics); children who have been engaged in a structured weekly yoga program for at least a month in the past year (based on our parents' poll, less than 5%). However, parents included could have past or actual experience in practicing yoga. Eligibility will be determined: by consulting the child's medical record; during a child medical visit at one of the sites or a virtual visit with the research team by administering the K-CPT2.
Sites / Locations
- Centre hospitalier universitaire Sainte-JustineRecruiting
- Centre universtaire de santé McGillRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Yoga group
Waitlist control group
Participants with CHD undergoing neurodevelopmental assessments and benefiting from the 8-week yoga intervention in addition to standard of care.
Participants with CHD undergoing neurodevelopmental assessments at the same time as the yoga group participants and benefiting from standard of care only during the 8 weeks of the intervention. The yoga intervention will be made available to all waitlist control group participants once their trial wave is completed.